Switzerland is to donate a maximum of 15 million shots of coronavirus vaccine in the first half of this year to the COVAX initiative for equitable vaccine distribution.
With a total of 34 million vaccines available for 2022, the Swiss population of 8.7 million is more than covered – even in the case of another booster campaign, the government said on Wednesday.
As such, it will make a maximum of 15 million shots available to the COVAX initiative, the multilateral project to funnel vaccines from richer to poorer countries in an effort to reduce inequalities.
“From the outset, as part of global efforts to manage the pandemic, Switzerland has been working to ensure that as many people as possible all over the world get access to safe and effective Covid-19 vaccines,” the government wroteExternal link.
It pointed to two previous gestures: a donation of four million AstraZeneca doses in June 2021 (after the Swiss health regulator did not approve it for use here), and the deferral of a purchase of a million doses of Moderna vaccine last December to allow COVAX to benefit from the freed-up production capacity.
While the vaccination rate in Switzerland stands at over 70%, many other countries – especially in Africa – have not managed to progress beyond small percentages of the population, as data from ReutersExternal link shows.
More
More
In the vaccine race, can COVAX help poorer countries catch up?
This content was published on
COVAX expects to start rolling out Covid-19 vaccines to poorer countries at the end of February. Can it really help them catch up?
The government also said on Wednesday it was planning to centralise the purchase of new drugs aimed at protecting those particularly vulnerable to Covid-19, for example immune-supressed people with underlying conditions.
Without naming specific medicines – simply saying they will “come up for approval in 2022” – the government said it would agree purchase guarantees with manufacturers so that they can be quickly made available to the people affected when available.
Last week, after the announcement that almost all public health measures to stem the spread of Covid-19 were ending in Switzerland, some groups of at-risk people voiced concern about their ongoing vulnerability to the disease.
The government added that such drugs for “passive immunisation” would be purchased in the future specifically for such vulnerable groups, rather than as an alternative to vaccination for the general public.
How is your country dealing with the return of stolen artifacts?
Western nations like Switzerland often have to deal with the process of recovering or returning looted artifacts which have been illegally imported. What’s the situation like in your country?
What do you think Switzerland’s Alain Berset can bring to the Council of Europe?
The former interior minister is to become the first Swiss Secretary General of the Council of Europe – which issues should his five-year term focus on?
Sylvain Saudan, ‘skier of the impossible’, dies aged 87
This content was published on
The Swiss father of extreme skiing pioneered descents from the Alps to the Himalayas – and became the sport’s first star.
Hayek family buys additional Swatch shares for nearly CHF11 million
This content was published on
Following the acquisition of registered shares worth over CHF20.6 million on Monday, the Hayek family made another purchase on Tuesday.
Suicide capsule to be used in Switzerland this year, says euthanasia organisation
This content was published on
The organisation “The Last Resort” has confirmed that the suicide capsule Sarco is to be used in Switzerland. This should happen this year, it said.
Ukrainian children flown to Switzerland for cancer treatment
This content was published on
The Swiss air rescue service Rega flew two Ukrainian children with cancer to Switzerland from a hospital in Kyiv hit by Russian missiles.
Swiss Solidarity raises over CHF10 million for victims of extreme weather
This content was published on
The money raised will be used to help those affected by the recent storms and flooding in the cantons of Ticino, Graubünden, and Valais.
Swiss giant Roche given green light for lung cancer drug in Canada
This content was published on
According to a recent study, Roche’s Alecensaro reduced the risk of recurrence or death by 76% compared to chemotherapy alone.
Swiss luxury watch market hit hard by China-led slump
This content was published on
Sales of Swiss-made luxury watches are in sharp retreat as nervous consumers reconsider splashing out on expensive timepieces and demand slumps.
This content was published on
The Swiss government has set out plans to contain the impact of a potential new wave of Covid-19 infections later this year.
Why Swiss participation in WHO’s Covid-19 vaccine plan matters
This content was published on
As the second coronavirus wave makes finding vaccines even more urgent, we look at Swiss participation in the WHO's vaccine pool.
Swiss should intensify cooperation with Covax, say experts
This content was published on
Rich countries should donate their surplus Covid-19 vaccines to poorer countries immediately, says the president of the international federation of pharma manufacturers.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.